Cardlytics Historical Income Statement

CDLX Stock

USD 3.93 0.13 3.42%

Historical analysis of Cardlytics income statement accounts such as Interest Income of 3.4 M, Depreciation And Amortization of 16.7 M or Interest Expense of 4.2 M can show how well Cardlytics performed in making a profits. Evaluating Cardlytics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Cardlytics's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Cardlytics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cardlytics is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

About Cardlytics Income Statement Analysis

Cardlytics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Cardlytics shareholders. The income statement also shows Cardlytics investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Cardlytics Income Statement Chart

At this time, Cardlytics' Selling And Marketing Expenses is fairly stable compared to the past year. Total Other Income Expense Net is likely to rise to about 1 M in 2024, whereas Interest Income is likely to drop slightly above 3.4 M in 2024.

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit Net Income From Continuing Ops

Total Revenue

Total revenue comprises all receipts Cardlytics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Cardlytics minus its cost of goods sold. It is profit before Cardlytics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Cardlytics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Cardlytics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.At this time, Cardlytics' Selling And Marketing Expenses is fairly stable compared to the past year. Total Other Income Expense Net is likely to rise to about 1 M in 2024, whereas Interest Income is likely to drop slightly above 3.4 M in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	33.7M	43.7M	29.5M	16.7M
Interest Income	297K	1.4M	3.8M	3.4M

Depreciation And Amortization Interest Income

Cardlytics income statement Correlations

	Tax Provision	Interest Income	Depreciation And Amortization	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Net Interest Income	Reconciled Depreciation	Non Operating Income Net Other	Non Recurring
Tax Provision		0.17	-0.58	-0.48	-0.63	-0.44	-0.42	-0.45	0.33	0.3	0.27	-0.43	0.23	-0.45	-0.53	0.28	0.27	0.27	0.18	0.64	-0.59	-0.4	0.02
Interest Income	0.17		-0.12	-0.06	-0.15	-0.01	0.01	-0.04	-0.03	0.03	0.17	-0.04	0.17	-0.02	-0.09	0.02	-0.79	0.02	0.17	0.11	-0.15	-0.26	-0.01
Depreciation And Amortization	-0.58	-0.12		0.96	0.92	0.89	0.88	0.95	-0.87	-0.86	-0.85	0.97	-0.81	0.9	0.99	-0.86	-0.15	-0.85	0.31	0.05	1.0	0.34	0.76
Selling General Administrative	-0.48	-0.06	0.96		0.91	0.97	0.96	0.99	-0.85	-0.78	-0.77	0.95	-0.73	0.97	0.99	-0.78	-0.11	-0.77	0.38	0.24	0.95	0.47	0.77
Selling And Marketing Expenses	-0.63	-0.15	0.92	0.91		0.85	0.81	0.86	-0.73	-0.84	-0.84	0.83	-0.8	0.87	0.93	-0.83	-0.14	-0.83	0.11	0.09	0.92	0.49	0.56
Total Revenue	-0.44	-0.01	0.89	0.97	0.85		1.0	0.98	-0.78	-0.67	-0.66	0.89	-0.61	1.0	0.94	-0.66	-0.1	-0.66	0.45	0.29	0.88	0.53	0.74
Gross Profit	-0.42	0.01	0.88	0.96	0.81	1.0		0.98	-0.78	-0.64	-0.63	0.9	-0.58	0.99	0.92	-0.64	-0.08	-0.63	0.49	0.28	0.87	0.48	0.77
Other Operating Expenses	-0.45	-0.04	0.95	0.99	0.86	0.98	0.98		-0.86	-0.74	-0.73	0.96	-0.69	0.98	0.98	-0.74	-0.09	-0.73	0.46	0.25	0.94	0.43	0.82
Operating Income	0.33	-0.03	-0.87	-0.85	-0.73	-0.78	-0.78	-0.86		0.77	0.75	-0.92	0.71	-0.77	-0.87	0.77	0.15	0.77	-0.67	-0.2	-0.89	-0.09	-0.87
Net Income From Continuing Ops	0.3	0.03	-0.86	-0.78	-0.84	-0.67	-0.64	-0.74	0.77		0.99	-0.83	0.98	-0.68	-0.84	1.0	0.21	1.0	-0.15	-0.19	-0.85	-0.07	-0.74
Ebit	0.27	0.17	-0.85	-0.77	-0.84	-0.66	-0.63	-0.73	0.75	0.99		-0.82	1.0	-0.67	-0.84	0.99	0.05	0.99	-0.14	-0.22	-0.85	-0.09	-0.75
Research Development	-0.43	-0.04	0.97	0.95	0.83	0.89	0.9	0.96	-0.92	-0.83	-0.82		-0.78	0.88	0.97	-0.83	-0.11	-0.83	0.45	0.15	0.96	0.19	0.88
Ebitda	0.23	0.17	-0.81	-0.73	-0.8	-0.61	-0.58	-0.69	0.71	0.98	1.0	-0.78		-0.63	-0.79	0.98	0.04	0.98	-0.09	-0.23	-0.81	-0.05	-0.72
Cost Of Revenue	-0.45	-0.02	0.9	0.97	0.87	1.0	0.99	0.98	-0.77	-0.68	-0.67	0.88	-0.63		0.94	-0.68	-0.1	-0.68	0.41	0.3	0.89	0.56	0.72
Total Operating Expenses	-0.53	-0.09	0.99	0.99	0.93	0.94	0.92	0.98	-0.87	-0.84	-0.84	0.97	-0.79	0.94		-0.84	-0.13	-0.83	0.34	0.16	0.99	0.39	0.78
Income Before Tax	0.28	0.02	-0.86	-0.78	-0.83	-0.66	-0.64	-0.74	0.77	1.0	0.99	-0.83	0.98	-0.68	-0.84		0.21	1.0	-0.16	-0.2	-0.85	-0.07	-0.74
Total Other Income Expense Net	0.27	-0.79	-0.15	-0.11	-0.14	-0.1	-0.08	-0.09	0.15	0.21	0.05	-0.11	0.04	-0.1	-0.13	0.21		0.2	0.07	0.18	-0.12	0.0	0.07
Net Income	0.27	0.02	-0.85	-0.77	-0.83	-0.66	-0.63	-0.73	0.77	1.0	0.99	-0.83	0.98	-0.68	-0.83	1.0	0.2		-0.16	-0.22	-0.84	-0.07	-0.74
Income Tax Expense	0.18	0.17	0.31	0.38	0.11	0.45	0.49	0.46	-0.67	-0.15	-0.14	0.45	-0.09	0.41	0.34	-0.16	0.07	-0.16		0.38	0.34	-0.08	0.67
Net Interest Income	0.64	0.11	0.05	0.24	0.09	0.29	0.28	0.25	-0.2	-0.19	-0.22	0.15	-0.23	0.3	0.16	-0.2	0.18	-0.22	0.38		0.03	0.18	0.46
Reconciled Depreciation	-0.59	-0.15	1.0	0.95	0.92	0.88	0.87	0.94	-0.89	-0.85	-0.85	0.96	-0.81	0.89	0.99	-0.85	-0.12	-0.84	0.34	0.03		0.33	0.76
Non Operating Income Net Other	-0.4	-0.26	0.34	0.47	0.49	0.53	0.48	0.43	-0.09	-0.07	-0.09	0.19	-0.05	0.56	0.39	-0.07	0.0	-0.07	-0.08	0.18	0.33		-0.04
Non Recurring	0.02	-0.01	0.76	0.77	0.56	0.74	0.77	0.82	-0.87	-0.74	-0.75	0.88	-0.72	0.72	0.78	-0.74	0.07	-0.74	0.67	0.46	0.76	-0.04

Click cells to compare fundamentals

Cardlytics Account Relationship Matchups

Cardlytics income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Income	829K	733K	297K	1.4M	3.8M	3.4M
Depreciation And Amortization	4.5M	12.4M	33.7M	43.7M	29.5M	16.7M
Interest Expense	1.4M	3.0M	12.6M	2.6M	6.2M	4.2M
Selling General Administrative	36.7M	46.5M	66.2M	81.4M	71.4M	48.4M
Selling And Marketing Expenses	43.8M	45.3M	66.0M	74.7M	44.8M	50.4M
Total Revenue	210.4M	186.9M	267.1M	298.5M	309.2M	213.1M
Gross Profit	79.5M	63.3M	103.3M	112.6M	130.4M	80.6M
Other Operating Expenses	227.8M	240.8M	364.0M	434.1M	444.9M	282.5M
Operating Income	(17.3M)	(53.9M)	(96.9M)	(135.5M)	(135.7M)	(128.9M)
Net Income From Continuing Ops	(17.1M)	(55.4M)	(144.3M)	(465.3M)	(134.7M)	(141.4M)
Ebit	(17.3M)	(51.9M)	(123.6M)	(462.7M)	(128.5M)	(134.9M)
Research Development	11.7M	17.5M	38.1M	54.4M	51.4M	27.7M
Ebitda	(12.8M)	(39.5M)	(89.9M)	(419.0M)	(99.0M)	(104.0M)
Cost Of Revenue	131.0M	123.6M	163.8M	185.9M	178.8M	132.5M
Total Operating Expenses	96.8M	117.2M	200.2M	248.2M	195.8M	141.3M
Income Before Tax	(17.1M)	(55.4M)	(136.4M)	(466.7M)	(134.7M)	(141.4M)
Total Other Income Expense Net	181K	(1.5M)	(13.8M)	(8.9M)	968K	1.0M
Net Income Applicable To Common Shares	(17.1M)	(55.4M)	(128.6M)	(465.3M)	(418.7M)	(397.8M)
Net Income	(17.7M)	(58.5M)	(128.6M)	(465.3M)	(134.7M)	(141.4M)
Income Tax Expense	548K	3.0M	(7.9M)	(1.4M)	134.7M	141.4M
Net Interest Income	(548K)	(3.0M)	(12.6M)	(2.6M)	(2.3M)	(2.5M)
Reconciled Depreciation	4.5M	11.6M	35.7M	43.7M	29.5M	20.6M
Non Operating Income Net Other	729K	1.5M	(1.3M)	(6.4M)	(7.3M)	(7.0M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cardlytics Historical Income Statement

About Cardlytics Income Statement Analysis

Cardlytics Income Statement Chart

Total Revenue

Gross Profit

Cardlytics income statement Correlations

Cardlytics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cardlytics income statement Accounts

Also Currently Popular

Additional Tools for Cardlytics Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Reconciled Depreciation	+ 1.0	Depreciation And Amortization
Gross Profit	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Income Before Tax	+ 1.0	Net Income From Continuing Ops
Net Income	+ 1.0	Net Income From Continuing Ops
Ebitda	+ 1.0	Ebit

Research Development	- 0.92	Operating Income
Reconciled Depreciation	- 0.89	Operating Income
Non Recurring	- 0.87	Operating Income
Total Operating Expenses	- 0.87	Operating Income
Operating Income	- 0.87	Depreciation And Amortization
Operating Income	- 0.86	Other Operating Expenses